HCPCS Table of Drugs (J-Codes)
1,209 HCPCS Level II J-codes (2026) for drugs administered other than by the oral method, parsed into drug name, dose, and route.
| Code | Drug / Substance | Dose | Route |
|---|---|---|---|
| J7121 | 5% dextrose in lactated ringers infusion | up to 1000 cc | |
| J7042 | 5% dextrose/normal saline | ||
| J7060 | 5% dextrose/water | ||
| J7604 | Acetylcysteine, compounded product, administered through dme, unit dose form, per gram | inhalation solution | |
| J7608 | Acetylcysteine, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram | inhalation solution | |
| J7352 | Afamelanotide implant | 1 mg | |
| J7610 | Albuterol, compounded product, administered through dme, concentrated form | 1 mg | inhalation solution |
| J7609 | Albuterol, compounded product, administered through dme, unit dose | 1 mg | inhalation solution |
| J7611 | Albuterol, fda-approved final product, non-compounded, administered through dme, concentrated form | 1 mg | inhalation solution |
| J7613 | Albuterol, fda-approved final product, non-compounded, administered through dme, unit dose | 1 mg | inhalation solution |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, fda-approved final product, non-compounded, administered through dme | up to 0.5 mg | |
| J0275 | Alprostadil urethral suppository | ||
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel | 10 mg | |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form | ||
| J7353 | Anacaulase-bcdb, 8.8% gel | 1 gram | |
| J8597 | Antiemetic drug, not otherwise specified | oral | |
| J8498 | Antiemetic drug, rectal/suppository, not otherwise specified | ||
| J7198 | Anti-inhibitor, per i.u. | ||
| J7197 | Antithrombin iii, per i.u. | ||
| J8501 | Aprepitant | 5 mg | oral |
| J7605 | Arformoterol, fda approved final product, non-compounded, administered through dme, unit dose form | 15 micrograms | inhalation solution |
| J7635 | Atropine, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7636 | Atropine, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7330 | Autologous cultured chondrocytes, implant | ||
| J7500 | Azathioprine | 50 mg | oral |
| J7501 | Azathioprine, parenteral | 100 mg | |
| J9031 | Bcg per instillation | ||
| J9030 | Bcg live intravesical instillation | 1 mg | |
| J7622 | Beclomethasone, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J3401 | Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes | per 0.1 ml | |
| J7624 | Betamethasone, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7628 | Bitolterol mesylate, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7629 | Bitolterol mesylate, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7634 | Budesonide, compounded product, administered through dme, concentrated form | per 0.25 milligram | inhalation solution |
| J7627 | Budesonide, compounded product, administered through dme, unit dose form | up to 0.5 mg | inhalation solution |
| J7633 | Budesonide, fda-approved final product, non-compounded, administered through dme, concentrated form | per 0.25 milligram | inhalation solution |
| J7626 | Budesonide, fda-approved final product, non-compounded, administered through dme, unit dose form | up to 0.5 mg | inhalation solution |
| J0570 | Buprenorphine implant | 74.2 mg | |
| J0575 | Buprenorphine/naloxone, greater than 10 mg buprenorphine | oral | |
| J0573 | Buprenorphine/naloxone, greater than 3 mg, but less than or equal to 6 mg buprenorphine | oral | |
| J0574 | Buprenorphine/naloxone, greater than 6 mg, but less than or equal to 10 mg buprenorphine | oral | |
| J0572 | Buprenorphine/naloxone, less than or equal to 3 mg buprenorphine | oral | |
| J0571 | Buprenorphine | 1 mg | oral |
| J8510 | Busulfan; oral | 2 mg | |
| J8515 | Cabergoline | 0.25 mg | oral |
| J0615 | Calcium acetate | 23 mg | oral |
| J7354 | Cantharidin for topical administration, 0.7%, single unit dose applicator | ||
| J8520 | Capecitabine | 150 mg | oral |
| J8521 | Capecitabine | 500 mg | oral |
| J8522 | Capecitabine | 50 mg | oral |
| J7335 | Capsaicin 8% patch, per 10 square centimeters | ||
| J7336 | Capsaicin 8% patch, per square centimeter | ||
| J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension | 100 ml | |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel | 1 mg | |
| J0604 | Cinacalcet | 1 mg | oral |
| J7999 | Compounded drug, not otherwise classified | ||
| J7304 | Contraceptive supply, hormone containing patch, each | ||
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | ||
| J7632 | Cromolyn sodium, compounded product, administered through dme, unit dose form | per 10 milligrams | inhalation solution |
| J7631 | Cromolyn sodium, fda-approved final product, non-compounded, administered through dme, unit dose form | per 10 milligrams | inhalation solution |
| J9070 | Cyclophosphamide | 100 mg | |
| J8530 | Cyclophosphamide; oral | 25 mg | |
| J7502 | Cyclosporine | 100 mg | oral |
| J7515 | Cyclosporine | 25 mg | oral |
| J9130 | Dacarbazine | 100 mg | |
| J7513 | Daclizumab, parenteral | 25 mg | |
| J0889 | Daprodustat | 1 mg | oral |
| J8541 | Dexamethasone | 0.25 mg | oral |
| J7637 | Dexamethasone, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7638 | Dexamethasone, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J1096 | Dexamethasone, lacrimal ophthalmic insert | 0.1 mg | |
| J8540 | Dexamethasone | 0.25 mg | oral |
| J1105 | Dexmedetomidine | 1 mcg | oral |
| J7639 | Dornase alfa, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | inhalation solution | |
| J3535 | Drug administered through a metered dose inhaler | ||
| J3520 | Edetate disodium | per 150 mg | |
| J0751 | Emtricitabine 200mg and tenofovir alafenamide 25mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis | oral | |
| J0750 | Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis | oral | |
| J7601 | Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form | 3 mg | |
| J0013 | Esketamine | 1 mg | nasal spray |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, each | 0.12mg per 24 hours; monthly vaginal ring | |
| J7307 | Etonogestrel implant system, including implant and supplies | ||
| J8560 | Etoposide; oral | 50 mg | |
| J7527 | Everolimus | 0.25 mg | oral |
| J7193 | Factor ix per i.u. | ||
| J7194 | Factor ix, complex, per i.u. | ||
| J7212 | Factor viia-jncw | 1 microgram | |
| J7189 | Factor viia | 1 microgram | |
| J7190 | Factor viii per i.u. | ||
| J7191 | Factor viii, per i.u. | ||
| J7192 | Factor viii per i.u., not otherwise specified | ||
| J0799 | Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis, not otherwise classified | ||
| J1440 | Fecal microbiota, live - jslm | 1 ml | |
| J0609 | Ferric citrate | 3 mg ferric iron | oral |
| J8562 | Fludarabine phosphate | 10 mg | oral |
| J7641 | Flunisolide, compounded product, administered through dme, unit dose, per milligram | inhalation solution | |
| J7606 | Formoterol fumarate, fda approved final product, non-compounded, administered through dme, unit dose form | 20 micrograms | inhalation solution |
| J7640 | Formoterol, compounded product, administered through dme, unit dose form | 12 micrograms | inhalation solution |
| J7310 | Ganciclovir, long-acting implant | 4.5 mg | |
| J8565 | Gefitinib | 250 mg | oral |
| J7642 | Glycopyrrolate, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7643 | Glycopyrrolate, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J9202 | Goserelin acetate implant | per 3.6 mg | |
| J7199 | Hemophilia clotting factor, not otherwise classified | ||
| J9226 | Histrelin implant | 50 mg | |
| J9225 | Histrelin implant | 50 mg | |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection | 1 mg | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | ||
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | ||
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection | 0.1 mg | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | ||
| J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection | 1 mg | |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | ||
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | ||
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection | 1 mg | |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection | 1 mg | |
| J7332 | Hyaluronan or derivative, triluron, for intra-articular injection | 1 mg | |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection | 1 mg | |
| J7333 | Hyaluronan or derivative, visco-3, for intra-articular injection, per dose | ||
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection | 1 mg | |
| J7131 | Hypertonic saline solution | 1 ml | |
| J7599 | Immunosuppressive drug, not otherwise classified | ||
| J7070 | d5w | 1000 cc | Infusion |
| J7100 | dextran 40 | 500 ml | Infusion |
| J7110 | dextran 75 | 500 ml | Infusion |
| J7030 | normal saline solution | 1000 cc | Infusion |
| J7050 | normal saline solution | 250 cc | Infusion |
| J7040 | normal saline solution, sterile | Infusion | |
| J0129 | abatacept | 10 mg | Injection |
| J0130 | Injection abciximab | 10 mg | |
| J0586 | abobotulinumtoxina | 5 units | Injection |
| J0138 | acetaminophen 10 mg and ibuprofen 3 mg | Injection | |
| J0136 | acetaminophen, not therapeutically equivalent to j0131 | 10 mg | Injection |
| J0134 | acetaminophen, not therapeutically equivalent to j0131 | 10 mg | Injection |
| J0137 | acetaminophen, not therapeutically equivalent to j0131 | 10 mg | Injection |
| J0131 | acetaminophen, not otherwise specified | 10 mg | Injection |
| J1120 | acetazolamide sodium | up to 500 mg | Injection |
| J0132 | acetylcysteine | 100 mg | Injection |
| J0133 | acyclovir | 5 mg | Injection |
| J0139 | adalimumab | 1 mg | Injection |
| J0135 | adalimumab | 20 mg | Injection |
| J7171 | adamts13, recombinant-krhn | 10 iu | Injection |
| J0153 | adenosine | 1 mg | Injection |
| J0151 | adenosine for diagnostic use | 1 mg | Injection |
| J0150 | adenosine for therapeutic use | 6 mg | Injection |
| J9354 | ado-trastuzumab emtansine | 1 mg | Injection |
| J0171 | adrenalin, epinephrine | 0.1 mg | Injection |
| J0172 | aducanumab-avwa | 2 mg | Injection |
| J0178 | aflibercept | 1 mg | Injection |
| J0177 | aflibercept hd | 1 mg | Injection |
| J0180 | agalsidase beta | 1 mg | Injection |
| J0200 | alatrofloxacin mesylate | 100 mg | Injection |
| J9015 | aldesleukin, per single use vial | Injection | |
| J0215 | alefacept | 0.5 mg | Injection |
| J9010 | alemtuzumab | 10 mg | Injection |
| J0202 | alemtuzumab | 1 mg | Injection |
| J0216 | alfentanil hydrochloride | 500 micrograms | Injection |
| J0205 | alglucerase | per 10 units | Injection |
| J0220 | alglucosidase alfa, not otherwise specified | 10 mg | Injection |
| J0221 | alglucosidase alfa | 10 mg | Injection |
| J0206 | allopurinol sodium | 1 mg | Injection |
| J0257 | alpha 1 proteinase inhibitor | 10 mg | Injection |
| J0256 | alpha 1 proteinase inhibitor, not otherwise specified | 10 mg | Injection |
| J0270 | alprostadil | 1.25 mcg | Injection |
| J2997 | alteplase recombinant | 1 mg | Injection |
| J0207 | amifostine | 500 mg | Injection |
| J0278 | amikacin sulfate | 100 mg | Injection |
| J0281 | aminocaproic acid | 1 gram | Injection |
| J0280 | aminophyllin | up to 250 mg | Injection |
| J0282 | amiodarone hydrochloride | 30 mg | Injection |
| J0283 | amiodarone hydrochloride | 30 mg | Injection |
| J0184 | amisulpride | 1 mg | Injection |
| J1320 | amitriptyline hcl | up to 20 mg | Injection |
| J9061 | amivantamab-vmjw | 2 mg | Injection |
| J0300 | amobarbital | up to 125 mg | Injection |
| J0285 | amphotericin b | 50 mg | Injection |
| J0288 | amphotericin b cholesteryl sulfate complex | 10 mg | Injection |
| J0287 | amphotericin b lipid complex | 10 mg | Injection |
| J0289 | amphotericin b liposome | 10 mg | Injection |
| J0290 | ampicillin sodium | 500 mg | Injection |
| J0295 | ampicillin sodium/sulbactam sodium | per 1.5 gm | Injection |
| J0348 | anidulafungin | 1 mg | Injection |
| J0491 | anifrolumab-fnia | 1 mg | Injection |
| J0350 | anistreplase | per 30 units | Injection |
| J7186 | antihemophilic factor viii/von willebrand factor complex, per factor viii i.u. | Injection | |
| J7196 | antithrombin recombinant, 50 i.u. | Injection | |
| J0364 | apomorphine hydrochloride | 1 mg | Injection |
| J0185 | aprepitant | 1 mg | Injection |
| J0365 | aprotonin, 10, 000 kiu | Injection | |
| J0395 | arbutamine hcl | 1 mg | Injection |
| J0884 | argatroban | 1 mg | Injection |
| J0883 | argatroban | 1 mg | Injection |
| J0891 | argatroban, not therapeutically equivalent to j0883 | 1 mg | Injection |
| J0892 | argatroban, not therapeutically equivalent to j0884 | 1 mg | Injection |
| J0898 | argatroban, not therapeutically equivalent to j0883 | 1 mg | Injection |
| J0899 | argatroban, not therapeutically equivalent to j0884 | 1 mg | Injection |
| J0402 | aripiprazole | 1 mg | Injection |
| J0401 | aripiprazole | 1 mg | Injection |
| J0400 | aripiprazole, intramuscular | 0.25 mg | Injection |
| J1942 | aripiprazole lauroxil | 1 mg | Injection |
| J1944 | aripiprazole lauroxil | 1 mg | Injection |
| J1943 | aripiprazole lauroxil | 1 mg | Injection |
| J9017 | arsenic trioxide | 1 mg | Injection |
| J0391 | artesunate | 1 mg | Injection |
| J9019 | asparaginase, 1 | 000 iu | Injection |
| J9020 | asparaginase, not otherwise specified, 10 | 000 units | Injection |
| J9021 | asparaginase, recombinant | 0.1 mg | Injection |
| J9022 | atezolizumab | 10 mg | Injection |
| J9024 | atezolizumab | 5 mg and hyaluronidase-tqjs | Injection |
| J3391 | atidarsagene autotemcel, per treatment | Injection | |
| J0461 | atropine sulfate | 0.01 mg | Injection |
| J0462 | atropine sulfate, not therapeutically equivalent to j0461 | 0.01 mg | Injection |
| J2910 | aurothioglucose | up to 50 mg | Injection |
| J2782 | avacincaptad pegol | 0.1 mg | Injection |
| J0219 | avalglucosidase alfa-ngpt | 4 mg | Injection |
| J9023 | avelumab | 10 mg | Injection |
| J9038 | axatilimab-csfr | 0.1 mg | Injection |
| J9025 | azacitidine | 1 mg | Injection |
| J0456 | azithromycin | 500 mg | Injection |
| J0457 | aztreonam | 100 mg | Injection |
| J0458 | aztreonam/avibactam | 7.5 mg/2.5 mg | Injection |
| J0475 | baclofen | 10 mg | Injection |
| J0476 | baclofen | 50 mcg for intrathecal trial | Injection |
| J0480 | basiliximab | 20 mg | Injection |
| J9037 | belantamab mafodotin-blmf | 0.5 mg | Injection |
| J0485 | belatacept | 1 mg | Injection |
| J0490 | belimumab | 10 mg | Injection |
| J9032 | belinostat | 10 mg | Injection |
| J9034 | bendamustine hcl | 1 mg | Injection |
| J9033 | bendamustine hydrochloride | 1 mg | Injection |
| J9058 | bendamustine hydrochloride | 1 mg | Injection |
| J9059 | bendamustine hydrochloride | 1 mg | Injection |
| J9036 | bendamustine hydrochloride | 1 mg | Injection |
| J9056 | bendamustine hydrochloride | 1 mg | Injection |
| J0517 | benralizumab | 1 mg | Injection |
| J0515 | benztropine mesylate | per 1 mg | Injection |
| J0702 | betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Injection | |
| J0520 | bethanechol chloride, myotonachol or urecholine | up to 5 mg | Injection |
| J3393 | betibeglogene autotemcel, per treatment | Injection | |
| J9035 | bevacizumab | 10 mg | Injection |
| J0565 | bezlotoxumab | 10 mg | Injection |
| J7351 | bimatoprost, intracameral implant | 1 microgram | Injection |
| J0190 | biperiden lactate | per 5 mg | Injection |
| J0583 | bivalirudin | 1 mg | Injection |
| J0582 | bivalirudin, not therapeutically equivalent to j0583 | 1 mg | Injection |
| J9040 | bleomycin sulfate | 15 units | Injection |
| J9039 | blinatumomab | 1 microgram | Injection |
| J9041 | bortezomib | 0.1 mg | Injection |
| J9054 | bortezomib | 0.1 mg | Injection |
| J9046 | bortezomib, not therapeutically equivalent to j9041 | 0.1 mg | Injection |
| J9048 | bortezomib, not therapeutically equivalent to j9041 | 0.1 mg | Injection |
| J9049 | bortezomib, not therapeutically equivalent to j9041 | 0.1 mg | Injection |
| J9051 | bortezomib, not therapeutically equivalent to j9041 | 0.1 mg | Injection |
| J9044 | bortezomib, not otherwise specified | 0.1 mg | Injection |
| J9042 | brentuximab vedotin | 1 mg | Injection |
| J1632 | brexanolone | 1 mg | Injection |
| J0179 | brolucizumab-dbll | 1 mg | Injection |
| J0945 | brompheniramine maleate | per 10 mg | Injection |
| J1939 | bumetanide | 0.5 mg | Injection |
| J0666 | bupivacaine liposome | 1 mg | Injection |
| J0665 | bupivicaine, not otherwise specified | 0.5 mg | Injection |
| J0576 | buprenorphine extended-release | 1 mg | Injection |
| J0578 | buprenorphine extended release, greater than 7 days and up to 28 days of therapy | Injection | |
| J0577 | buprenorphine extended-release, less than or equal to 7 days of therapy | Injection | |
| J0592 | buprenorphine hydrochloride | 0.1 mg | Injection |
| J0584 | burosumab-twza 1 mg | Injection | |
| J0594 | busulfan | 1 mg | injection |
| J0595 | butorphanol tartrate | 1 mg | Injection |
| J0597 | c-1 esterase inhibitor, berinert | 10 units | Injection |
| J0598 | c-1 esterase inhibitor, cinryze | 10 units | Injection |
| J0599 | c-1 esterase inhibitor | 10 units | Injection |
| J0596 | c1 esterase inhibitor, ruconest | 10 units | Injection |
| J9043 | cabazitaxel | 1 mg | Injection |
| J9064 | cabazitaxel, not therapeutically equivalent to j9043 | 1 mg | Injection |
| J0739 | cabotegravir, fda approved prescription, only for use as hiv pre-exposure prophylaxis | 1mg | Injection |
| J0741 | cabotegravir and rilpivirine | 2mg/3mg | Injection |
| J0706 | caffeine citrate | 5 mg | Injection |
| J9118 | calaspargase pegol-mknl | 10 units | Injection |
| J0630 | calcitonin salmon | up to 400 units | Injection |
| J0636 | calcitriol | 0.1 mcg | Injection |
| J0618 | calcium chloride | 2 mg | Injection |
| J0610 | calcium gluconate | per 10 ml | Injection |
| J0612 | calcium gluconate, not otherwise specified | 10 mg | Injection |
| J0613 | calcium gluconate, not therapeutically equivalent to j0612 | 10 mg | Injection |
| J0611 | calcium gluconate | per 10 ml | Injection |
| J0620 | calcium glycerophosphate and calcium lactate | per 10 ml | Injection |
| J0638 | canakinumab | 1 mg | Injection |
| J9045 | carboplatin | 50 mg | Injection |
| J0675 | carboprost tromethamine | 0.1 mg | Injection |
| J9047 | carfilzomib | 1 mg | Injection |
| J9050 | carmustine | 100 mg | Injection |
| J9052 | carmustine, not therapeutically equivalent to j9050 | 100 mg | Injection |
| J1426 | casimersen | 10 mg | Injection |
| J0637 | caspofungin acetate | 5 mg | Injection |
| J0690 | cefazolin sodium | 500 mg | Injection |
| J0689 | cefazolin sodium, not therapeutically equivalent to j0690 | 500 mg | Injection |
| J0688 | cefazolin sodium, not therapeutically equivalent to j0690 | 500 mg | Injection |
| J0687 | cefazolin sodium, not therapeutically equivalent to j0690 | 500 mg | Injection |
| J0692 | cefepime hydrochloride | 500 mg | Injection |
| J0701 | cefepime hydrochloride, not therapeutically equivalent to maxipime | 500 mg | Injection |
| J0703 | cefepime hydrochloride, not therapeutically equivalent to maxipime | 500 mg | Injection |
| J0699 | cefiderocol | 10 mg | Injection |
| J0693 | cefiderocol | 5 mg | Injection |
| J0698 | cefotaxime sodium, per gm | Injection | |
| J0525 | cefotetan disodium | 10 mg | Injection |
| J0694 | cefoxitin sodium | 1 gm | Injection |
| J0712 | ceftaroline fosamil | 10 mg | Injection |
| J0714 | ceftazidime and avibactam | 0.5 g/0.125 g | Injection |
| J0713 | ceftazidime | per 500 mg | Injection |
| J0715 | ceftizoxime sodium | per 500 mg | Injection |
| J0681 | ceftobiprole medocaril sodium | 3 mg | Injection |
| J0695 | ceftolozane 50 mg and tazobactam 25 mg | Injection | |
| J0696 | ceftriaxone sodium | per 250 mg | Injection |
| J9119 | cemiplimab-rwlc | 1 mg | Injection |
| J0716 | centruroides immune f2 | up to 120 milligrams | Injection |
| J1890 | cephalothin sodium | up to 1 gram | Injection |
| J0710 | cephapirin sodium | up to 1 gm | Injection |
| J0567 | cerliponase alfa | 1 mg | Injection |
| J0717 | certolizumab pegol | 1 mg | Injection |
| J1201 | cetirizine hydrochloride | 0.5 mg | Injection |
| J9055 | cetuximab | 10 mg | Injection |
| J0720 | chloramphenicol sodium succinate | up to 1 gm | Injection |
| J1990 | chlordiazepoxide hcl | up to 100 mg | Injection |
| J2402 | chloroprocaine hydrochloride | per 1 mg | Injection |
| J2401 | chloroprocaine hydrochloride | per 1 mg | Injection |
| J2400 | chloroprocaine hydrochloride | per 30 ml | Injection |
| J0390 | chloroquine hydrochloride | up to 250 mg | Injection |
| J1205 | chlorothiazide sodium | per 500 mg | Injection |
| J3230 | chlorpromazine hcl | up to 50 mg | Injection |
| J0725 | chorionic gonadotropin, per 1, 000 usp units | Injection | |
| J0740 | cidofovir | 375 mg | Injection |
| J0743 | cilastatin sodium; imipenem | per 250 mg | Injection |
| J1203 | cipaglucosidase alfa-atga | 5 mg | Injection |
| J0744 | ciprofloxacin for intravenous infusion | 200 mg | Injection |
| J9060 | cisplatin, powder or solution | 10 mg | Injection |
| J9065 | cladribine | per 1 mg | Injection |
| J0759 | clevidipine butyrate | 1 mg | Injection |
| J0736 | clindamycin phosphate | 300 mg | Injection |
| J0737 | clindamycin phosphate, not therapeutically equivalent to j0736 | 300 mg | Injection |
| J9027 | clofarabine | 1 mg | Injection |
| J0735 | clonidine hydrochloride | 1 mg | Injection |
| J7213 | coagulation factor ix, ixinity, 1 i.u. | Injection | |
| J7169 | coagulation factor xa, inactivated-zhzo | 10 mg | Injection |
| J0745 | codeine phosphate | per 30 mg | Injection |
| J0760 | colchicine | per 1 mg | Injection |
| J0770 | colistimethate sodium | up to 150 mg | Injection |
| J0775 | collagenase, clostridium histolyticum | 0.01 mg | Injection |
| J7173 | concizumab-mtci | 0.5 mg | Injection |
| J9057 | copanlisib | 1 mg | Injection |
| J0795 | corticorelin ovine triflutate | 1 microgram | Injection |
| J0801 | corticotropin | up to 40 units | Injection |
| J0802 | corticotropin | up to 40 units | Injection |
| J0800 | corticotropin | up to 40 units | Injection |
| J9275 | cosibelimab-ipdl | 2 mg | Injection |
| J0834 | cosyntropin | 0.25 mg | Injection |
| J0833 | cosyntropin, not otherwise specified | 0.25 mg | Injection |
| J0791 | crizanlizumab-tmca | 5 mg | Injection |
| J0841 | crotalidae immune f2 | 120 mg | Injection |
| J0840 | crotalidae polyvalent immune fab | up to 1 gram | Injection |
| J1307 | crovalimab-akkz | 10 mg | Injection |
| J9071 | cyclophosphamide | 5 mg | Injection |
| J9076 | cyclophosphamide | 5 mg | Injection |
| J9073 | cyclophosphamide | 5 mg | Injection |
| J9072 | cyclophosphamide | 5 mg | Injection |
| J9075 | cyclophosphamide, not otherwise specified | 5 mg | Injection |
| J9074 | cyclophosphamide | 5 mg | Injection |
| J7516 | cyclosporine | 250 mg | Injection |
| J9100 | cytarabine | 100 mg | Injection |
| J9098 | cytarabine liposome | 10 mg | Injection |
| J0850 | cytomegalovirus immune globulin intravenous, per vial | Injection | |
| J9120 | dactinomycin | 0.5 mg | Injection |
| J0875 | dalbavancin | 5 mg | Injection |
| J1645 | dalteparin sodium | per 2500 iu | Injection |
| J0878 | daptomycin | 1 mg | Injection |
| J0874 | daptomycin, not therapeutically equivalent to j0878 | 1 mg | Injection |
| J0877 | daptomycin, not therapeutically equivalent to j0878 | 1 mg | Injection |
| J0873 | daptomycin, not therapeutically equivalent to j0878 or j0872 | 1 mg | Injection |
| J0872 | daptomycin, unrefrigerated, not therapeutically equivalent to j0878 or j0873 | 1 mg | Injection |
| J9145 | daratumumab | 10 mg | Injection |
| J9144 | daratumumab | 10 mg and hyaluronidase-fihj | Injection |
| J0882 | darbepoetin alfa | 1 microgram | Injection |
| J0881 | darbepoetin alfa | 1 microgram | Injection |
| J9011 | datopotamab deruxtecan-dlnk | 1 mg | Injection |
| J9150 | daunorubicin | 10 mg | Injection |
| J9151 | daunorubicin citrate, liposomal formulation | 10 mg | Injection |
| J0589 | daxibotulinumtoxina-lanm | 1 unit | Injection |
| J0894 | decitabine | 1 mg | Injection |
| J0893 | decitabine, not therapeutically equivalent to j0894 | 1 mg | Injection |
| J0895 | deferoxamine mesylate | 500 mg | Injection |
| J9155 | degarelix | 1 mg | Injection |
| J1413 | delandistrogene moxeparvovec-rokl, per therapeutic dose | Injection | |
| J9160 | denileukin diftitox | 300 micrograms | Injection |
| J9161 | denileukin diftitox-cxdl | 1 mcg | Injection |
| J0897 | denosumab | 1 mg | Injection |
| J0591 | deoxycholic acid | 1 mg | Injection |
| J1000 | depo-estradiol cypionate | up to 5 mg | Injection |
| J2597 | desmopressin acetate | per 1 mcg | Injection |
| J1095 | dexamethasone 9 percent, intraocular | 1 microgram | Injection |
| J1094 | dexamethasone acetate | 1 mg | Injection |
| J7312 | dexamethasone, intravitreal implant | 0.1 mg | Injection |
| J1100 | dexamethasone sodium phosphate | 1 mg | Injection |
| J1190 | dexrazoxane hydrochloride | per 250 mg | Injection |
| J3360 | diazepam | up to 5 mg | Injection |
| J1730 | diazoxide | up to 300 mg | Injection |
| J1130 | diclofenac sodium | 0.5 mg | Injection |
| J0500 | dicyclomine hcl | up to 20 mg | Injection |
| J9165 | diethylstilbestrol diphosphate | 250 mg | Injection |
| J0879 | difelikefalin | 0.1 microgram | Injection |
| J1162 | digoxin immune fab, per vial | Injection | |
| J1160 | digoxin | up to 0.5 mg | Injection |
| J1110 | dihydroergotamine mesylate | per 1 mg | Injection |
| J1163 | diltiazem hydrochloride | 0.5 mg | Injection |
| J1240 | dimenhydrinate | up to 50 mg | Injection |
| J0470 | dimercaprol | per 100 mg | Injection |
| J1200 | diphenhydramine hcl | up to 50 mg | Injection |
| J1245 | dipyridamole | per 10 mg | Injection |
| J1212 | dmso, dimethyl sulfoxide, 50% | 50 ml | Injection |
| J1250 | dobutamine hydrochloride | per 250 mg | Injection |
| J9171 | docetaxel | 1 mg | Injection |
| J9174 | docetaxel | 1 mg | Injection |
| J9172 | docetaxel | 1 mg | Injection |
| J1260 | dolasetron mesylate | 10 mg | Injection |
| J0175 | donanemab-azbt | 2 mg | Injection |
| J1265 | dopamine hcl | 40 mg | Injection |
| J1267 | doripenem | 10 mg | Injection |
| J9272 | dostarlimab-gxly | 10 mg | Injection |
| J1270 | doxercalciferol | 1 mcg | Injection |
| J9000 | doxorubicin hydrochloride | 10 mg | Injection |
| J1271 | doxycycline hyclate | 1 mg | Injection |
| J1810 | droperidol and fentanyl citrate | up to 2 ml ampule | Injection |
| J1790 | droperidol | up to 5 mg | Injection |
| J9173 | durvalumab | 10 mg | Injection |
| J1180 | dyphylline | up to 500 mg | Injection |
| J1290 | ecallantide | 1 mg | Injection |
| J1300 | eculizumab | 10 mg | Injection |
| J1299 | eculizumab | 2 mg | Injection |
| J1301 | edaravone | 1 mg | Injection |
| J0600 | edetate calcium disodium | up to 1000 mg | Injection |
| J9361 | efbemalenograstim alfa-vuxw | 0.5 mg | Injection |
| J9334 | efgartigimod alfa | 2 mg and hyaluronidase-qvfc | Injection |
| J9332 | efgartigimod alfa-fcab | 2mg | Injection |
| J1449 | eflapegrastim-xnst | 0.1 mg | Injection |
| J3387 | elivaldogene autotemcel, per treatment | Injection | |
| J9175 | elliotts' b solution | 1 ml | Injection |
| J1322 | elosulfase alfa | 1 mg | Injection |
| J9176 | elotuzumab | 1 mg | Injection |
| J1323 | elranatamab-bcmm | 1 mg | Injection |
| J9210 | emapalumab-lzsg | 1 mg | Injection |
| J7170 | emicizumab-kxwh | 0.5 mg | Injection |
| J9177 | enfortumab vedotin-ejfv | 0.25 mg | Injection |
| J1324 | enfuvirtide | 1 mg | Injection |
| J1650 | enoxaparin sodium | 10 mg | Injection |
| J9321 | epcoritamab-bysp | 0.16 mg | Injection |
| J0169 | epinephrine, not therapeutically equivalent to j0165 | 0.1 mg | Injection |
| J0173 | epinephrine, not therapeutically equivalent to j0171 | 0.1 mg | Injection |
| J0166 | epinephrine, not therapeutically equivalent to j0165 | 0.1 mg | Injection |
| J0162 | epinephrine, not therapeutically equivalent to j0165 | 0.1 mg | Injection |
| J0167 | epinephrine, not therapeutically equivalent to j0165 | 0.1 mg | Injection |
| J0164 | epinephrine in sodium chloride | 0.1 mg | Injection |
| J0163 | epinephrine in sodium chloride | 0.1 mg | Injection |
| J0168 | epinephrine, not therapeutically equivalent to j0165 | 0.1 mg | Injection |
| J0165 | epinephrine, not otherwise specified | 0.1 mg | Injection |
| J9178 | epirubicin hcl | 2 mg | Injection |
| J0886 | epoetin alfa | 1000 units | Injection |
| J0885 | epoetin alfa | 1000 units | Injection |
| J0887 | epoetin beta | 1 microgram | Injection |
| J0888 | epoetin beta | 1 microgram | Injection |
| J1325 | epoprostenol | 0.5 mg | Injection |
| J1327 | eptifibatide | 5 mg | Injection |
| J3032 | eptinezumab-jjmr | 1 mg | Injection |
| J0122 | eravacycline | 1 mg | Injection |
| J1330 | ergonovine maleate | up to 0.2 mg | Injection |
| J9179 | eribulin mesylate | 0.1 mg | Injection |
| J1335 | ertapenem sodium | 500 mg | Injection |
| J1364 | erythromycin lactobionate | per 500 mg | Injection |
| J1805 | esmolol hydrochloride | 10 mg | Injection |
| J1806 | esmolol hydrochloride, not therapeutically equivalent to j1805 | 10 mg | Injection |
| J1370 | esomeprazole sodium | 1 mg | Injection |
| J1380 | estradiol valerate | up to 10 mg | Injection |
| J1410 | estrogen conjugated | per 25 mg | Injection |
| J1435 | estrone | per 1 mg | Injection |
| J1438 | etanercept | 25 mg | Injection |
| J0606 | etelcalcetide | 0.1 mg | Injection |
| J1428 | eteplirsen | 10 mg | Injection |
| J1807 | ethacrynate sodium | 1 mg | Injection |
| J1430 | ethanolamine oleate | 100 mg | Injection |
| J1436 | etidronate disodium | per 300 mg | Injection |
| J9181 | etoposide | 10 mg | Injection |
| J1411 | etranacogene dezaparvovec-drlb, per therapeutic dose | Injection | |
| J1305 | evinacumab-dgnb | 5mg | Injection |
| J3392 | exagamglogene autotemcel, per treatment | Injection | |
| J7202 | factor ix, albumin fusion protein, idelvion, 1 i.u. | Injection | |
| J7203 | Injection factor ix, glycopegylated | 1 iu | |
| J7195 | factor ix per iu, not otherwise specified | Injection | |
| J7200 | factor ix, rixubis, per iu | Injection | |
| J7201 | factor ix, fc fusion protein, alprolix, 1 i.u. | Injection | |
| J7210 | factor viii, 1 i.u. | Injection | |
| J7204 | factor viii, antihemophilic factor, glycopegylated-exei, per iu | Injection | |
| J7211 | factor viii, 1 i.u. | Injection | |
| J7182 | factor viii, per iu | Injection | |
| J7209 | factor viii, 1 i.u. | Injection | |
| J7188 | factor viii, per i.u. | Injection | |
| J7207 | factor viii, pegylated, 1 i.u. | Injection | |
| J7208 | factor viii, pegylated-aucl, 1 i.u. | Injection | |
| J7185 | factor viii, per i.u. | Injection | |
| J7205 | factor viii fc fusion protein, per iu | Injection | |
| J7214 | factor viii/von willebrand factor complex, recombinant, per factor viii i.u. | Injection | |
| J7175 | factor x, 1 i.u. | Injection | |
| J7180 | factor xiii, 1 i.u. | Injection | |
| J7181 | factor xiii a-subunit, per iu | Injection | |
| J1308 | famotidine | 0.25 mg | Injection |
| J9358 | fam-trastuzumab deruxtecan-nxki | 1 mg | Injection |
| J2777 | faricimab-svoa | 0.1 mg | Injection |
| J3010 | fentanyl citrate | 0.1 mg | Injection |
| J1439 | ferric carboxymaltose | 1 mg | Injection |
| J1437 | ferric derisomaltose | 10 mg | Injection |
| J1444 | ferric pyrophosphate citrate powder | 0.1 mg of iron | Injection |
| J1443 | ferric pyrophosphate citrate solution | 0.1 mg of iron | Injection |
| J1445 | ferric pyrophosphate citrate solution | 0.1 mg of iron | Injection |
| J1414 | fidanacogene elaparvovec-dzkt, per therapeutic dose | Injection | |
| J1442 | filgrastim, excludes biosimilars | 1 microgram | Injection |
| J7174 | fitusiran | 0.04 mg | Injection |
| J9200 | floxuridine | 500 mg | Injection |
| J1450 | Injection fluconazole | 200 mg | |
| J9185 | fludarabine phosphate | 50 mg | Injection |
| J7313 | fluocinolone acetonide, intravitreal implant | 0.01 mg | Injection |
| J7311 | fluocinolone acetonide, intravitreal implant | 0.01 mg | Injection |
| J7314 | fluocinolone acetonide, intravitreal implant | 0.01 mg | Injection |
| J9190 | fluorouracil | 500 mg | Injection |
| J2680 | fluphenazine decanoate | up to 25 mg | Injection |
| J2679 | fluphenazine hcl | 1.25 mg | Injection |
| J1808 | folic acid | 0.1 mg | Injection |
| J1451 | fomepizole | 15 mg | Injection |
| J1452 | fomivirsen sodium, intraocular | 1.65 mg | Injection |
| J1652 | fondaparinux sodium | 0.5 mg | Injection |
| J1453 | fosaprepitant | 1 mg | Injection |
| J1434 | fosaprepitant | 1 mg | Injection |
| J1456 | fosaprepitant, not therapeutically equivalent to j1453 | 1 mg | Injection |
| J7356 | foscarbidopa 0.25 mg/foslevodopa 5 mg | Injection | |
| J1455 | foscarnet sodium | per 1000 mg | Injection |
| J1809 | fosdenopterin | 0.1 mg | Injection |
| J1454 | fosnetupitant 235 mg and palonosetron 0.25 mg | Injection | |
| J3031 | fremanezumab-vfrm | 1 mg | Injection |
| J9395 | fulvestrant | 25 mg | Injection |
| J9394 | fulvestrant not therapeutically equivalent to j9395 | 25 mg | Injection |
| J9393 | fulvestrant, not therapeutically equivalent to j9395 | 25 mg | Injection |
| J1938 | furosemide | 1 mg | Injection |
| J1941 | furosemide | 20 mg | Injection |
| J1940 | furosemide | up to 20 mg | Injection |
| J1457 | gallium nitrate | 1 mg | Injection |
| J1458 | galsulfase | 1 mg | Injection |
| J1460 | gamma globulin, intramuscular | 1 cc | Injection |
| J1560 | gamma globulin, intramuscular, over 10 cc | Injection | |
| J1570 | ganciclovir sodium | 500 mg | Injection |
| J1574 | ganciclovir sodium, not therapeutically equivalent to j1570 | 500 mg | Injection |
| J1580 | garamycin, gentamicin | up to 80 mg | Injection |
| J1590 | gatifloxacin | 10 mg | Injection |
| J9196 | gemcitabine hydrochloride, not therapeutically equivalent to j9201 | 200 mg | Injection |
| J9184 | gemcitabine hydrochloride | 200 mg | Injection |
| J9198 | gemcitabine hydrochloride | 100 mg | Injection |
| J9199 | gemcitabine hydrochloride | 200 mg | Injection |
| J9201 | gemcitabine hydrochloride, not otherwise specified | 200 mg | Injection |
| J9203 | gemtuzumab ozogamicin | 0.1 mg | Injection |
| J9300 | gemtuzumab ozogamicin | 5 mg | Injection |
| J0223 | givosiran | 0.5 mg | Injection |
| J1595 | glatiramer acetate | 20 mg | Injection |
| J9286 | glofitamab-gxbm | 2.5 mg | Injection |
| J1612 | glucagon | 0.01 mg | Injection |
| J1611 | glucagon hydrochloride, not therapeutically equivalent to j1610 | per 1 mg | Injection |
| J1610 | glucagon hydrochloride | per 1 mg | Injection |
| J1596 | glycopyrrolate | 0.1 mg | Injection |
| J1598 | glycopyrrolate, not therapeutically equivalent to j1596 | 0.1 mg | Injection |
| J1597 | glycopyrrolate | 0.1 mg | Injection |
| J1600 | gold sodium thiomalate | up to 50 mg | Injection |
| J1602 | golimumab, for intravenous use | 1 mg | Injection |
| J1429 | golodirsen | 10 mg | Injection |
| J1620 | gonadorelin hydrochloride | per 100 mcg | Injection |
| J1627 | granisetron, extended-release | 0.1 mg | Injection |
| J1626 | granisetron hydrochloride | 100 mcg | Injection |
| J1628 | guselkumab | 1 mg | Injection |
| J1631 | haloperidol decanoate | per 50 mg | Injection |
| J1630 | haloperidol | up to 5 mg | Injection |
| J1640 | hemin | 1 mg | Injection |
| J1642 | heparin sodium | per 10 units | Injection |
| J1644 | heparin sodium | per 1000 units | Injection |
| J1643 | heparin sodium, not therapeutically equivalent to j1644 | per 1000 units | Injection |
| J1571 | hepatitis b immune globulin, intramuscular | 0.5 ml | Injection |
| J1573 | hepatitis b immune globulin, intravenous | 0.5 ml | Injection |
| J1675 | histrelin acetate | 10 micrograms | Injection |
| J7177 | human fibrinogen concentrate | 1 mg | Injection |
| J7178 | human fibrinogen concentrate, not otherwise specified | 1 mg | Injection |
| J3472 | hyaluronidase, ovine, preservative free, per 1000 usp units | Injection | |
| J3471 | hyaluronidase, ovine, preservative free, per 1 usp unit | Injection | |
| J3473 | hyaluronidase, recombinant, 1 usp unit | Injection | |
| J3470 | hyaluronidase | up to 150 units | Injection |
| J0360 | hydralazine hcl | up to 20 mg | Injection |
| J1700 | hydrocortisone acetate | up to 25 mg | Injection |
| J1710 | hydrocortisone sodium phosphate | up to 50 mg | Injection |
| J1720 | hydrocortisone sodium succinate | up to 100 mg | Injection |
| J1171 | hydromorphone | 0.1 mg | Injection |
| J1170 | hydromorphone | up to 4 mg | Injection |
| J3425 | hydroxocobalamin, intramuscular | 10 mcg | Injection |
| J3424 | hydroxocobalamin, intravenous | 25 mg | Injection |
| J1725 | hydroxyprogesterone caproate | 1 mg | Injection |
| J1726 | hydroxyprogesterone caproate | 10 mg | Injection |
| J1729 | hydroxyprogesterone caproate, not otherwise specified | 10 mg | Injection |
| J3410 | hydroxyzine hcl | up to 25 mg | Injection |
| J1980 | hyoscyamine sulfate | up to 0.25 mg | Injection |
| J1746 | ibalizumab-uiyk | 10 mg | Injection |
| J1740 | ibandronate sodium | 1 mg | Injection |
| J1741 | ibuprofen | 100 mg | Injection |
| J1742 | ibutilide fumarate | 1 mg | Injection |
| J1744 | icatibant | 1 mg | Injection |
| J9211 | idarubicin hydrochloride | 5 mg | Injection |
| J1743 | idursulfase | 1 mg | Injection |
| J9208 | ifosfamide | 1 gram | Injection |
| J1749 | iloprost | 0.1 mcg | Injection |
| J0870 | imetelstat | 1 mg | Injection |
| J1786 | imiglucerase | 10 units | Injection |
| J0742 | imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg | Injection | |
| J1552 | immune globulin | 500 mg | Injection |
| J1554 | immune globulin | 500 mg | Injection |
| J1556 | immune globulin | 500 mg | Injection |
| J1551 | immune globulin | 100 mg | Injection |
| J1555 | immune globulin | 100 mg | Injection |
| J1572 | immune globulin, intravenous, non-lyophilized | 500 mg | Injection |
| J1569 | immune globulin, non-lyophilized | 500 mg | Injection |
| J1557 | immune globulin, intravenous, non-lyophilized | 500 mg | Injection |
| J1561 | immune globulin, non-lyophilized | 500 mg | Injection |
| J1559 | immune globulin | 100 mg | Injection |
| J1575 | immune globulin/hyaluronidase | 100 mg immuneglobulin | Injection |
| J1566 | immune globulin, intravenous, lyophilized, not otherwise specified | 500 mg | Injection |
| J1599 | immune globulin, intravenous, non-lyophilized, not otherwise specified | 500 mg | Injection |
| J1568 | immune globulin, intravenous, non-lyophilized | 500 mg | Injection |
| J1576 | immune globulin, intravenous, non-lyophilized | 500 mg | Injection |
| J1459 | immune globulin, intravenous, non-lyophilized | 500 mg | Injection |
| J1562 | immune globulin | 100 mg | Injection |
| J1558 | immune globulin | 100 mg | Injection |
| J1306 | inclisiran | 1 mg | Injection |
| J0588 | incobotulinumtoxin a | 1 unit | Injection |
| J9220 | indigotindisulfonate sodium | 1 mg | Injection |
| J1823 | inebilizumab-cdon | 1 mg | Injection |
| J1748 | infliximab-dyyb | 10 mg | Injection |
| J1745 | infliximab, excludes biosimilar | 10 mg | Injection |
| J9229 | inotuzumab ozogamicin | 0.1 mg | Injection |
| J1815 | insulin | per 5 units | Injection |
| J9213 | interferon, alfa-2a, recombinant | 3 million units | Injection |
| J9214 | interferon, alfa-2b, recombinant | 1 million units | Injection |
| J9212 | interferon alfacon-1, recombinant | 1 microgram | Injection |
| J9215 | interferon, alfa-n3, 250 | 000 iu | Injection |
| J1826 | interferon beta-1a | 30 mcg | Injection |
| J1830 | interferon beta-1b | 0.25 mg | Injection |
| J9216 | interferon, gamma 1-b | 3 million units | Injection |
| J9228 | ipilimumab | 1 mg | Injection |
| J9206 | irinotecan | 20 mg | Injection |
| J9205 | irinotecan liposome | 1 mg | Injection |
| J1750 | iron dextran | 50 mg | Injection |
| J1756 | iron sucrose | 1 mg | Injection |
| J9227 | isatuximab-irfc | 10 mg | Injection |
| J1833 | isavuconazonium | 1 mg | Injection |
| J1834 | isoniazid | 1 mg | Injection |
| J1835 | itraconazole | 50 mg | Injection |
| J3365 | iv, urokinase, 250, 000 i.u. vial | Injection | |
| J9207 | ixabepilone | 1 mg | Injection |
| J1840 | kanamycin sulfate | up to 500 mg | Injection |
| J1850 | kanamycin sulfate | up to 75 mg | Injection |
| J1885 | ketorolac tromethamine | per 15 mg | Injection |
| J1920 | labetalol hydrochloride | 5 mg | Injection |
| J1921 | labetalol hydrochloride, not therapeutically equivalent to j1920 | 5 mg | Injection |
| J0593 | lanadelumab-flyo | 1 mg | Injection |
| J1930 | lanreotide | 1 mg | Injection |
| J1932 | lanreotide | 1 mg | Injection |
| J1931 | laronidase | 0.1 mg | Injection |
| J0174 | lecanemab-irmb | 1 mg | Injection |
| J0691 | lefamulin | 1 mg | Injection |
| J0738 | lenacapavir, fda approved prescription, only for use as hiv pre-exposure prophylaxis | 1 mg | Injection |
| J1961 | lenacapavir | 1 mg | Injection |
| J1945 | lepirudin | 50 mg | Injection |
| J0640 | leucovorin calcium | per 50 mg | Injection |
| J1951 | leuprolide acetate for depot suspension | 0.25 mg | Injection |
| J1954 | leuprolide acetate for depot suspension | 7.5 mg | Injection |
| J1950 | leuprolide acetate | per 3.75 mg | Injection |
| J1953 | levetiracetam | 10 mg | Injection |
| J1955 | levocarnitine | per 1 gm | Injection |
| J1956 | levofloxacin | 250 mg | Injection |
| J0642 | levoleucovorin | 0.5 mg | Injection |
| J0641 | levoleucovorin, not otherwise specified | 0.5 mg | Injection |
| J1960 | levorphanol tartrate | up to 2 mg | Injection |
| J0651 | levothyroxine sodium, not therapeutically equivalent to j0650 | 10 mcg | Injection |
| J0652 | levothyroxine sodium, not therapeutically equivalent to j0650 | 10 mcg | Injection |
| J0650 | levothyroxine sodium, not otherwise specified | 10 mcg | Injection |
| J2001 | lidocaine hcl for intravenous infusion | 10 mg | Injection |
| J2002 | lidocaine hcl in 5% dextrose | 1 mg | Injection |
| J2004 | lidocaine hcl with epinephrine | 1 mg | Injection |
| J2003 | lidocaine hydrochloride | 1 mg | Injection |
| J2010 | lincomycin hcl | up to 300 mg | Injection |
| J2020 | linezolid | 200 mg | Injection |
| J2021 | linezolid, not therapeutically equivalent to j2020 | 200 mg | Injection |
| J0654 | liothyronine | 1 mcg | Injection |
| J9153 | liposomal | 1 mg daunorubicin and 2.27 mg cytarabine | Injection |
| J9359 | loncastuximab tesirine-lpyl | 0.075 mg | Injection |
| J2060 | lorazepam | 2 mg | Injection |
| J3394 | lovotibeglogene autotemcel, per treatment | Injection | |
| J0224 | lumasiran | 0.5 mg | Injection |
| J9223 | lurbinectedin | 0.1 mg | Injection |
| J0896 | luspatercept-aamt | 0.25 mg | Injection |
| J3475 | magnesium sulfate | per 500 mg | Injection |
| J2151 | mannitol | 250 mg | Injection |
| J2150 | mannitol, 25% in 50 ml | Injection | |
| J9353 | margetuximab-cmkb | 5 mg | Injection |
| J7172 | marstacimab-hncq | 0.5 mg | Injection |
| J2170 | mecasermin | 1 mg | Injection |
| J9230 | mechlorethamine hydrochloride | 10 mg | Injection |
| J1050 | medroxyprogesterone acetate | 1 mg | Injection |
| J1738 | meloxicam | 1 mg | Injection |
| J1737 | meloxicam | 1 mg | Injection |
| J1736 | meloxicam | 1 mg | Injection |
| J9249 | melphalan | 1 mg | Injection |
| J9246 | melphalan | 1 mg | Injection |
| J9247 | melphalan flufenamide | 1mg | Injection |
| J9248 | melphalan | 1 mg | Injection |
| J9245 | melphalan hydrochloride, not otherwise specified | 50 mg | Injection |
| J2180 | meperidine and promethazine hcl | up to 50 mg | Injection |
| J2175 | meperidine hydrochloride | per 100 mg | Injection |
| J0670 | mepivacaine hydrochloride | per 10 ml | Injection |
| J2182 | mepolizumab | 1 mg | Injection |
| J2185 | meropenem | 100 mg | Injection |
| J2186 | meropenem and vaborbactam | 10mg/10mg | Injection |
| J2184 | meropenem, not therapeutically equivalent to j2185 | 100 mg | Injection |
| J2183 | meropenem, not therapeutically equivalent to j2185 | 100 mg | Injection |
| J9209 | mesna | 200 mg | Injection |
| J0380 | metaraminol bitartrate | per 10 mg | Injection |
| J1230 | methadone hcl | up to 10 mg | Injection |
| J2800 | methocarbamol | up to 10 ml | Injection |
| J9255 | methotrexate, not therapeutically equivalent to j9260 | 50 mg | Injection |
| J9260 | methotrexate sodium | 50 mg | Injection |
| J0210 | methyldopate hcl | up to 250 mg | Injection |
| J2210 | methylergonovine maleate | up to 0.2 mg | Injection |
| J2212 | methylnaltrexone | 0.1 mg | Injection |
| J1010 | methylprednisolone acetate | 1 mg | Injection |
| J1020 | methylprednisolone acetate | 20 mg | Injection |
| J1030 | methylprednisolone acetate | 40 mg | Injection |
| J1040 | methylprednisolone acetate | 80 mg | Injection |
| J2919 | methylprednisolone sodium succinate | 5 mg | Injection |
| J2930 | methylprednisolone sodium succinate | up to 125 mg | Injection |
| J2920 | methylprednisolone sodium succinate | up to 40 mg | Injection |
| J2765 | metoclopramide hcl | up to 10 mg | Injection |
| J0616 | metoprolol tartrate | 1 mg | Injection |
| J1836 | metronidazole | 10 mg | Injection |
| J2246 | micafungin in sodium, not therapeutically equivalent to j2248 | 1 mg | Injection |
| J2248 | micafungin sodium | 1 mg | Injection |
| J2247 | micafungin sodium not thereapeutically equivalent to j2248 | 1 mg | Injection |
| J2250 | midazolam hydrochloride | per 1 mg | Injection |
| J2252 | midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250 | 1 mg | Injection |
| J2251 | midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250 | 1 mg | Injection |
| J2253 | midazolam | 1 mg | Injection |
| J2260 | milrinone lactate | 5 mg | Injection |
| J2265 | minocycline hydrochloride | 1 mg | Injection |
| J2267 | mirikizumab-mrkz | 1 mg | Injection |
| J9063 | mirvetuximab soravtansine-gynx | 1 mg | Injection |
| J9280 | mitomycin | 5 mg | Injection |
| J9293 | mitoxantrone hydrochloride | per 5 mg | Injection |
| J9204 | mogamulizumab-kpkc | 1 mg | Injection |
| J2271 | morphine sulfate | 100mg | Injection |
| J2272 | morphine sulfate, not therapeutically equivalent to j2270 | up to 10 mg | Injection |
| J2274 | morphine sulfate, preservative-free for epidural or intrathecal use | 10 mg | Injection |
| J2275 | morphine sulfate | per 10 mg | Injection |
| J2270 | morphine sulfate | up to 10 mg | Injection |
| J9350 | mosunetuzumab-axgb | 1 mg | Injection |
| J2277 | motixafortide | 0.25 mg | Injection |
| J9313 | moxetumomab pasudotox-tdfk | 0.01 mg | Injection |
| J2280 | moxifloxacin | 100 mg | Injection |
| J2281 | moxifloxacin, not therapeutically equivalent to j2280 | 100 mg | Injection |
| J7519 | mycophenolate mofetil | 10 mg | Injection |
| J2290 | nafcillin sodium | 20 mg | Injection |
| J2291 | nafcillin sodium | 20 mg | Injection |
| J2300 | nalbuphine hydrochloride | per 10 mg | Injection |
| J2312 | naloxone hydrochloride, not otherwise specified | 0.01 mg | Injection |
| J2310 | naloxone hydrochloride | per 1 mg | Injection |
| J2313 | naloxone hydrochloride | 0.01 mg | Injection |
| J2311 | naloxone hydrochloride | 1 mg | Injection |
| J2315 | naltrexone, depot form | 1 mg | Injection |
| J2320 | nandrolone decanoate | up to 50 mg | Injection |
| J2323 | natalizumab | 1 mg | Injection |
| J9348 | naxitamab-gqgk | 1 mg | Injection |
| J9295 | necitumumab | 1 mg | Injection |
| J9261 | nelarabine | 50 mg | Injection |
| J2711 | neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg | Injection | |
| J2710 | neostigmine methylsulfate | up to 0.5 mg | Injection |
| J2325 | nesiritide | 0.1 mg | Injection |
| J2404 | nicardipine | 0.1 mg | Injection |
| J9256 | nipocalimab-aahu | 3 mg | Injection |
| J2305 | nitroglycerin | 5 mg | Injection |
| J9299 | nivolumab | 1 mg | Injection |
| J9289 | nivolumab | 2 mg and hyaluronidase-nvhy | Injection |
| J9298 | nivolumab and relatlimab-rmbw | 3 mg/1 mg | Injection |
| J9028 | nogapendekin alfa inbakicept-pmln, for intravesical use | 1 microgram | Injection |
| J2326 | nusinersen | 0.1 mg | Injection |
| J9301 | obinutuzumab | 10 mg | Injection |
| J2350 | ocrelizumab | 1 mg | Injection |
| J2351 | ocrelizumab | 1 mg and hyaluronidase-ocsq | Injection |
| J7316 | ocriplasmin | 0.125 mg | Injection |
| J2353 | octreotide, depot form for intramuscular injection | 1 mg | Injection |
| J2354 | octreotide, non-depot form for subcutaneous or intravenous injection | 25 mcg | Injection |
| J9302 | ofatumumab | 10 mg | Injection |
| J2359 | olanzapine | 0.5 mg | Injection |
| J2358 | olanzapine, long-acting | 1 mg | Injection |
| J9285 | olaratumab | 10 mg | Injection |
| J0218 | olipudase alfa-rpcp | 1 mg | Injection |
| J9262 | omacetaxine mepesuccinate | 0.01 mg | Injection |
| J0121 | omadacycline | 1 mg | Injection |
| J2357 | omalizumab | 5 mg | Injection |
| J0585 | onabotulinumtoxina | 1 unit | Injection |
| J3399 | onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes | Injection | |
| J2405 | ondansetron hydrochloride | per 1 mg | Injection |
| J2355 | oprelvekin | 5 mg | Injection |
| J2406 | oritavancin | 10 mg | Injection |
| J2407 | oritavancin | 10 mg | Injection |
| J2360 | orphenadrine citrate | up to 60 mg | Injection |
| J2700 | oxacillin sodium | up to 250 mg | Injection |
| J9263 | oxaliplatin | 0.5 mg | Injection |
| J2410 | oxymorphone hcl | up to 1 mg | Injection |
| J2460 | oxytetracycline hcl | up to 50 mg | Injection |
| J2590 | oxytocin | up to 10 units | Injection |
| J9267 | paclitaxel | 1 mg | Injection |
| J9265 | paclitaxel | 30 mg | Injection |
| J9264 | paclitaxel protein-bound particles | 1 mg | Injection |
| J9259 | paclitaxel protein-bound particles, not therapeutically equivalent to j9264 | 1 mg | Injection |
| J9258 | paclitaxel protein-bound particles, not therapeutically equivalent to j9264 | 1 mg | Injection |
| J2425 | palifermin | 50 micrograms | Injection |
| J2428 | paliperidone palmitate extended release | 1 mg | Injection |
| J2427 | paliperidone palmitate extended release | 1 mg | Injection |
| J2426 | paliperidone palmitate extended release | 1 mg | Injection |
| J2469 | palonosetron hcl | 25 mcg | Injection |
| J2468 | palonosetron hydrochloride | 25 micrograms | Injection |
| J2430 | pamidronate disodium | per 30 mg | Injection |
| J9303 | panitumumab | 10 mg | Injection |
| J2471 | pantoprazole, not therapeutically equivalent to j2470 | 40 mg | Injection |
| J2470 | pantoprazole sodium | 40 mg | Injection |
| J2472 | pantoprazole sodium in sodium chloride | 40 mg | Injection |
| J2440 | papaverine hcl | up to 60 mg | Injection |
| J2501 | paricalcitol | 1 mcg | Injection |
| J2502 | pasireotide long acting | 1 mg | Injection |
| J0222 | patisiran | 0.1 mg | Injection |
| J2504 | pegademase bovine | 25 iu | Injection |
| J2503 | pegaptanib sodium | 0.3 mg | Injection |
| J9266 | pegaspargase, per single dose vial | Injection | |
| J2781 | pegcetacoplan, intravitreal | 1 mg | Injection |
| J2505 | pegfilgrastim | 6 mg | Injection |
| J2506 | pegfilgrastim, excludes biosimilar | 0.5 mg | Injection |
| J0890 | peginesatide | 0.1 mg | Injection |
| J2507 | pegloticase | 1 mg | Injection |
| J2508 | pegunigalsidase alfa-iwxj | 1 mg | Injection |
| J9271 | pembrolizumab | 1 mg | Injection |
| J9296 | pemetrexed, not therapeutically equivalent to j9305 | 10 mg | Injection |
| J9322 | pemetrexed, not therapeutically equivalent to j9305 | 10 mg | Injection |
| J9292 | pemetrexed dipotassium | 10 mg | Injection |
| J9323 | pemetrexed ditromethamine | 10 mg | Injection |
| J9294 | pemetrexed, not therapeutically equivalent to j9305 | 10 mg | Injection |
| J9305 | pemetrexed, not otherwise specified | 10 mg | Injection |
| J9304 | pemetrexed | 10 mg | Injection |
| J9324 | pemetrexed | 10 mg | Injection |
| J9297 | pemetrexed, not therapeutically equivalent to j9305 | 10 mg | Injection |
| J9314 | pemetrexed, not therapeutically equivalent to j9305 | 10 mg | Injection |
| J0561 | penicillin g benzathine, 100 | 000 units | Injection |
| J0558 | penicillin g benzathine and penicillin g procaine, 100 | 000 units | Injection |
| J2540 | penicillin g potassium, up to 600 | 000 units | Injection |
| J2510 | penicillin g procaine, aqueous, up to 600 | 000 units | Injection |
| J2516 | pentamidine isethionate | 1 mg | Injection |
| J2513 | pentastarch, 10% solution | 100 ml | Injection |
| J3070 | pentazocine | 30 mg | Injection |
| J2515 | pentobarbital sodium | per 50 mg | Injection |
| J9268 | pentostatin | 10 mg | Injection |
| J2547 | peramivir | 1 mg | Injection |
| J3310 | perphenazine | up to 5 mg | Injection |
| J9306 | pertuzumab | 1 mg | Injection |
| J9316 | pertuzumab, trastuzumab, and hyaluronidase-zzxf | per 10 mg | Injection |
| J2561 | phenobarbital sodium | 1 mg | Injection |
| J2560 | phenobarbital sodium | up to 120 mg | Injection |
| J2760 | phentolamine mesylate | up to 5 mg | Injection |
| J2370 | phenylephrine hcl | up to 1 ml | Injection |
| J2371 | phenylephrine hydrochloride | 20 micrograms | Injection |
| J2372 | phenylephrine hydrochloride | 20 micrograms | Injection |
| J2373 | phenylephrine hydrochloride | 20 micrograms | Injection |
| J1165 | phenytoin sodium | per 50 mg | Injection |
| J3430 | phytonadione | per 1 mg | Injection |
| J2543 | piperacillin sodium/tazobactam sodium | 1 gram/0.125 grams | Injection |
| J2998 | plasminogen, human-tvmh | 1 mg | Injection |
| J0291 | plazomicin | 5 mg | Injection |
| J2562 | plerixafor | 1 mg | Injection |
| J9270 | plicamycin | 2.5 mg | Injection |
| J9309 | polatuzumab vedotin-piiq | 1 mg | Injection |
| J9600 | porfimer sodium | 75 mg | Injection |
| J1837 | posaconazole | 1 mg | Injection |
| J3480 | potassium chloride | per 2 meq | Injection |
| J9376 | pozelimab-bbfg | 1 mg | Injection |
| J9307 | pralatrexate | 1 mg | Injection |
| J2730 | pralidoxime chloride | up to 1 gm | Injection |
| J2650 | prednisolone acetate | up to 1 ml | Injection |
| J2690 | procainamide hcl | up to 1 gm | Injection |
| J0780 | prochlorperazine | up to 10 mg | Injection |
| J2675 | progesterone | per 50 mg | Injection |
| J2950 | promazine hcl | up to 25 mg | Injection |
| J2550 | promethazine hcl | up to 50 mg | Injection |
| J2704 | propofol | 10 mg | Injection |
| J1800 | propranolol hcl | up to 1 mg | Injection |
| J2720 | protamine sulfate | per 10 mg | Injection |
| J2724 | protein c concentrate, intravenous, human | 10 iu | Injection |
| J7165 | prothrombin complex concentrate, human-lans, per i.u. of factor ix activity | Injection | |
| J2725 | protirelin | per 250 mcg | Injection |
| J3415 | pyridoxine hcl | 100 mg | Injection |
| J2770 | quinupristin/dalfopristin | 500 mg | Injection |
| J9308 | ramucirumab | 5 mg | Injection |
| J2778 | ranibizumab | 0.1 mg | Injection |
| J2779 | ranibizumab, via intravitreal implant | 0.1 mg | Injection |
| J2780 | ranitidine hydrochloride | 25 mg | Injection |
| J2783 | rasburicase | 0.5 mg | Injection |
| J1303 | ravulizumab-cwvz | 10 mg | Injection |
| J2785 | regadenoson | 0.1 mg | Injection |
| J0248 | remdesivir | 1 mg | Injection |
| J3402 | remestemcel-l-rknd, per therapeutic dose | Injection | |
| J2249 | remimazolam | 1 mg | Injection |
| J2786 | reslizumab | 1 mg | Injection |
| J2993 | reteplase | 18.1 mg | Injection |
| J9345 | retifanlimab-dlwr | 1 mg | Injection |
| J0349 | rezafungin | 1 mg | Injection |
| J2790 | rho d immune globulin, human, full dose | 300 micrograms | Injection |
| J2788 | rho d immune globulin, human, minidose | 50 micrograms | Injection |
| J2791 | rho immune globulin, intramuscular or intravenous | 100 iu | Injection |
| J2792 | rho d immune globulin, intravenous, human, solvent detergent | 100 iu | Injection |
| J2804 | rifampin | 1 mg | Injection |
| J2793 | rilonacept | 1 mg | Injection |
| J0587 | rimabotulinumtoxinb | 100 units | Injection |
| J2327 | risankizumab-rzaa, intravenous | 1 mg | Injection |
| J2798 | risperidone | 0.5 mg | Injection |
| J2794 | risperidone | 0.5 mg | Injection |
| J2801 | risperidone | 0.5 mg | Injection |
| J2799 | risperidone | 1 mg | Injection |
| J9310 | rituximab | 100 mg | Injection |
| J9312 | rituximab | 10 mg | Injection |
| J9311 | rituximab 10 mg and hyaluronidase | Injection | |
| J2797 | rolapitant | 0.5 mg | Injection |
| J9315 | romidepsin | 1 mg | Injection |
| J9319 | romidepsin, lyophilized | 0.1 mg | Injection |
| J9318 | romidepsin, non-lyophilized | 0.1 mg | Injection |
| J2796 | romiplostim | 10 micrograms | Injection |
| J2802 | romiplostim | 1 microgram | Injection |
| J3111 | romosozumab-aqqg | 1 mg | Injection |
| J2795 | ropivacaine hydrochloride | 1 mg | Injection |
| J9333 | rozanolixizumab-noli | 1 mg | Injection |
| J9317 | sacituzumab govitecan-hziy | 2.5 mg | Injection |
| J2820 | sargramostim | 50 mcg | Injection |
| J2840 | sebelipase alfa | 1 mg | Injection |
| J2850 | secretin, synthetic, human | 1 microgram | Injection |
| J3247 | secukinumab, intravenous | 1 mg | Injection |
| J2860 | siltuximab | 10 mg | Injection |
| J2805 | sincalide | 5 micrograms | Injection |
| J2806 | sincalide, not therapeutically equivalent to j2805 | 5 micrograms | Injection |
| J9331 | sirolimus protein-bound particles | 1 mg | Injection |
| J2916 | sodium ferric gluconate complex in sucrose injection | 12.5 mg | Injection |
| J0211 | sodium nitrite 3 mg and sodium thiosulfate 125 mg | Injection | |
| J0209 | sodium thiosulfate | 100 mg | Injection |
| J0208 | sodium thiosulfate | 100 mg | Injection |
| J2940 | somatrem | 1 mg | Injection |
| J2941 | somatropin | 1 mg | Injection |
| J3320 | spectinomycin dihydrochloride | up to 2 gm | Injection |
| J1747 | spesolimab-sbzo | 1 mg | Injection |
| J0697 | sterile cefuroxime sodium | per 750 mg | Injection |
| J2995 | streptokinase, per 250 | 000 iu | Injection |
| J3000 | streptomycin | up to 1 gm | Injection |
| J9320 | streptozocin | 1 gram | Injection |
| J0330 | succinylcholine chloride | up to 20 mg | Injection |
| J2865 | sulfamethoxazole 5 mg and trimethoprim 1 mg | Injection | |
| J3030 | sumatriptan succinate | 6 mg | Injection |
| J1302 | sutimlimab-jome | 10 mg | Injection |
| J9349 | tafasitamab-cxix | 2 mg | Injection |
| J9269 | tagraxofusp-erzs | 10 micrograms | Injection |
| J3060 | taliglucerase alfa | 10 units | Injection |
| J9325 | talimogene laherparepvec, per 1 million plaque forming units | Injection | |
| J3055 | talquetamab-tgvs | 0.25 mg | Injection |
| J9026 | tarlatamab-dlle | 1 mg | Injection |
| J1447 | tbo-filgrastim | 1 microgram | Injection |
| J1446 | tbo-filgrastim | 5 micrograms | Injection |
| J9274 | tebentafusp-tebn | 1 microgram | Injection |
| J9380 | teclistamab-cqyv | 0.5 mg | Injection |
| J3090 | tedizolid phosphate | 1 mg | Injection |
| J3095 | telavancin | 10 mg | Injection |
| J9326 | telisotuzumab vedotin-tllv | 1 mg | Injection |
| J9328 | temozolomide | 1 mg | Injection |
| J9330 | temsirolimus | 1 mg | Injection |
| J3101 | tenecteplase | 1 mg | Injection |
| J9381 | teplizumab-mzwv | 5 mcg | Injection |
| J3241 | teprotumumab-trbw | 10 mg | Injection |
| J3105 | terbutaline sulfate | up to 1 mg | Injection |
| J3110 | teriparatide | 10 mcg | Injection |
| J1080 | testosterone cypionate, 1 cc | 200 mg | Injection |
| J1071 | testosterone cypionate | 1 mg | Injection |
| J1060 | testosterone cypionate and estradiol cypionate | up to 1 ml | Injection |
| J1072 | testosterone cypionate | 1 mg | Injection |
| J1070 | testosterone cypionate | up to 100 mg | Injection |
| J3121 | testosterone enanthate | 1 mg | Injection |
| J0900 | testosterone enanthate and estradiol valerate | up to 1 cc | Injection |
| J3120 | testosterone enanthate | up to 100 mg | Injection |
| J3130 | testosterone enanthate | up to 200 mg | Injection |
| J3150 | testosterone propionate | up to 100 mg | Injection |
| J3140 | testosterone suspension | up to 50 mg | Injection |
| J3145 | testosterone undecanoate | 1 mg | Injection |
| J1670 | tetanus immune globulin, human | up to 250 units | Injection |
| J0120 | tetracycline | up to 250 mg | Injection |
| J2356 | tezepelumab-ekko | 1 mg | Injection |
| J2810 | theophylline | per 40 mg | Injection |
| J3411 | thiamine hcl | 100 mg | Injection |
| J3280 | thiethylperazine maleate | up to 10 mg | Injection |
| J9340 | thiotepa | 15 mg | Injection |
| J9342 | thiotepa, not otherwise specified | 1 mg | Injection |
| J9341 | thiotepa | 1 mg | Injection |
| J3240 | thyrotropin alpha, provided in 1.1 mg vial | 0.9 mg | Injection |
| J3243 | tigecycline | 1 mg | Injection |
| J3244 | tigecycline, not therapeutically equivalent to j3243 | 1 mg | Injection |
| J3245 | tildrakizumab | 1 mg | Injection |
| J1655 | tinzaparin sodium | 1000 iu | Injection |
| J3246 | tirofiban hcl | 0.25 mg | Injection |
| J9329 | tislelizumab-jsgr | 1mg | Injection |
| J9273 | tisotumab vedotin-tftv | 1 mg | Injection |
| J3260 | tobramycin sulfate | up to 80 mg | Injection |
| J3262 | tocilizumab | 1 mg | Injection |
| J1304 | tofersen | 1 mg | Injection |
| J2670 | tolazoline hcl | up to 25 mg | Injection |
| J9351 | topotecan | 0.1 mg | Injection |
| J3263 | toripalimab-tpzi | 1 mg | Injection |
| J3265 | torsemide | 10 mg/ml | Injection |
| J9352 | trabectedin | 0.1 mg | Injection |
| J3290 | tranexamic acid | 5 mg | Injection |
| J3291 | tranexamic acid in sodium chloride | 5 mg | Injection |
| J9356 | trastuzumab | 10 mg and hyaluronidase-oysk | Injection |
| J9355 | trastuzumab, excludes biosimilar | 10 mg | Injection |
| J7355 | travoprost, intracameral implant | 1 microgram | Injection |
| J9347 | tremelimumab-actl | 1 mg | Injection |
| J0614 | treosulfan | 50 mg | Injection |
| J3285 | treprostinil | 1 mg | Injection |
| J3301 | triamcinolone acetonide, not otherwise specified | 10 mg | Injection |
| J3300 | triamcinolone acetonide, preservative free | 1 mg | Injection |
| J3304 | triamcinolone acetonide, preservative-free, extended-release, microsphere formulation | 1 mg | Injection |
| J3299 | triamcinolone acetonide | 1 mg | Injection |
| J3302 | triamcinolone diacetate | per 5 mg | Injection |
| J3303 | triamcinolone hexacetonide | per 5 mg | Injection |
| J3400 | triflupromazine hcl | up to 20 mg | Injection |
| J1448 | trilaciclib | 1mg | Injection |
| J3250 | trimethobenzamide hcl | up to 200 mg | Injection |
| J3305 | trimetrexate glucuronate | per 25 mg | Injection |
| J3316 | triptorelin, extended-release | 3.75 mg | Injection |
| J3315 | triptorelin pamoate | 3.75 mg | Injection |
| J2329 | ublituximab-xiiy | 1mg | Injection |
| J3350 | urea | up to 40 gm | Injection |
| J3355 | urofollitropin | 75 iu | Injection |
| J3364 | urokinase | 5000 iu vial | Injection |
| J1412 | valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes | Injection | |
| J3379 | valproate sodium | 5 mg | Injection |
| J9357 | valrubicin, intravesical | 200 mg | Injection |
| J3370 | vancomycin hcl | 500 mg | Injection |
| J3376 | vancomycin hcl, not therapeutically equivalent to j3373 | 10 mg | Injection |
| J3371 | vancomycin hcl, not therapeutically equivalent to j3370 | 500 mg | Injection |
| J3372 | vancomycin hcl, not therapeutically equivalent to j3370 | 500 mg | Injection |
| J3373 | vancomycin hydrochloride | 10 mg | Injection |
| J3374 | vancomycin hydrochloride not therapeutically equivalent to j3373 | 10 mg | Injection |
| J3375 | vancomycin hydrochloride, not therapeutically equivalent to j3373 | 10 mg | Injection |
| J2598 | vasopressin | 1 unit | Injection |
| J2599 | vasopressin, not therapeutically equivalent to j2598 | 1 unit | Injection |
| J2601 | vasopressin | 1 unit | Injection |
| J2596 | vasopressin, not therapeutically equivalent to j2598 | 1 unit | Injection |
| J3380 | vedolizumab, intravenous | 1 mg | Injection |
| J3385 | velaglucerase alfa | 100 units | Injection |
| J0217 | velmanase alfa-tycv | 1 mg | Injection |
| J3396 | verteporfin | 0.1 mg | Injection |
| J3397 | vestronidase alfa-vjbk | 1 mg | Injection |
| J1427 | viltolarsen | 10 mg | Injection |
| J9360 | vinblastine sulfate | 1 mg | Injection |
| J9371 | vincristine sulfate liposome | 1 mg | Injection |
| J9390 | vinorelbine tartrate | 10 mg | Injection |
| J3420 | vitamin b-12 cyanocobalamin | up to 1000 mcg | Injection |
| J7183 | von willebrand factor complex, wilate, 1 i.u. vwf:rco | Injection | |
| J7187 | von willebrand factor complex, per iu vwf:rco | Injection | |
| J7179 | von willebrand factor, 1 i.u. vwf:rco | Injection | |
| J3398 | voretigene neparvovec-rzyl, 1 billion vector genomes | Injection | |
| J3465 | voriconazole | 10 mg | Injection |
| J0225 | vutrisiran | 1 mg | Injection |
| J9276 | zanidatamab-hrii | 2 mg | Injection |
| J9382 | zenocutuzumab-zbco | 1 mg | Injection |
| J2278 | ziconotide | 1 microgram | Injection |
| J3485 | zidovudine | 10 mg | Injection |
| J3486 | ziprasidone mesylate | 10 mg | Injection |
| J9400 | ziv-aflibercept | 1 mg | Injection |
| J1326 | zolbetuximab-clzb | 2 mg | Injection |
| J3489 | zoledronic acid | 1 mg | Injection |
| J0668 | Instillation, bupivacaine and meloxicam | 1 mg/0.03 mg | |
| J7342 | Instillation, ciprofloxacin otic suspension | 6 mg | |
| J0911 | Instillation, taurolidine 1.35 mg and heparin sodium 100 units | ||
| J1811 | Insulin for administration through dme | per 50 units | |
| J1812 | Insulin | per 5 units | |
| J1817 | Insulin for administration through dme | per 50 units | |
| J1813 | Insulin for administration through dme | per 50 units | |
| J1814 | Insulin | per 5 units | |
| J7299 | Intrauterine copper contraceptive | ||
| J7300 | Intrauterine copper contraceptive | ||
| J9029 | Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose | ||
| J7645 | Ipratropium bromide, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7644 | Ipratropium bromide, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7647 | Isoetharine hcl, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7650 | Isoetharine hcl, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7648 | Isoetharine hcl, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7649 | Isoetharine hcl, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7657 | Isoproterenol hcl, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7660 | Isoproterenol hcl, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J7658 | Isoproterenol hcl, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7659 | Isoproterenol hcl, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | inhalation solution | |
| J3570 | Laetrile, amygdalin, vitamin b17 | ||
| J0607 | Lanthanum carbonate | 5 mg | oral |
| J0608 | Lanthanum carbonate, powder, not therapeutically equivalent to j0607 | 5 mg | oral |
| J9217 | Leuprolide acetate | 7.5 mg | |
| J9219 | Leuprolide acetate implant | 65 mg | |
| J9218 | Leuprolide acetate | per 1 mg | |
| J1952 | Leuprolide injectable, camcevi | 1 mg | |
| J7607 | Levalbuterol, compounded product, administered through dme, concentrated form | 0.5 mg | inhalation solution |
| J7615 | Levalbuterol, compounded product, administered through dme, unit dose | 0.5 mg | inhalation solution |
| J7612 | Levalbuterol, fda-approved final product, non-compounded, administered through dme, concentrated form | 0.5 mg | inhalation solution |
| J7614 | Levalbuterol, fda-approved final product, non-compounded, administered through dme, unit dose | 0.5 mg | inhalation solution |
| J7306 | Levonorgestrel implant system, including implants and supplies | ||
| J7302 | Levonorgestrel-releasing intrauterine contraceptive system | 52 mg | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system | 19.5 mg | |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system | 52 mg | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system | 52 mg | |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system | 13.5 mg | |
| J2062 | Loxapine for inhalation | 1 mg | |
| J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral | 250 mg | |
| J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral | 25 mg | |
| J7665 | Mannitol, administered through an inhaler | 5 mg | |
| J8600 | Melphalan; oral | 2 mg | |
| J7670 | Metaproterenol sulfate, compounded product, administered through dme, unit dose form | per 10 milligrams | inhalation solution |
| J7667 | Metaproterenol sulfate, compounded product, concentrated form | per 10 milligrams | inhalation solution |
| J7668 | Metaproterenol sulfate, fda-approved final product, non-compounded, administered through dme, concentrated form | per 10 milligrams | inhalation solution |
| J7669 | Metaproterenol sulfate, fda-approved final product, non-compounded, administered through dme, unit dose form | per 10 milligrams | inhalation solution |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer | per 1 mg | |
| J8611 | Methotrexate | 2.5 mg | oral |
| J8610 | Methotrexate; oral | 2.5 mg | |
| J9250 | Methotrexate sodium | 5 mg | |
| J8612 | Methotrexate | 2.5 mg | oral |
| J7309 | Methyl aminolevulinate for topical administration, 16.8% | 1 gram | |
| J7509 | Methylprednisolone oral | per 4 mg | |
| J1202 | Miglustat | 65 mg | oral |
| J9282 | Mitomycin, intravesical instillation | 1 mg | |
| J7315 | Mitomycin, ophthalmic | 0.2 mg | |
| J9281 | Mitomycin pyelocalyceal instillation | 1 mg | |
| J7401 | Mometasone furoate sinus implant | 10 micrograms | |
| J7402 | Mometasone furoate sinus implant | 10 micrograms | |
| J7505 | Muromonab-cd3, parenteral | 5 mg | |
| J7528 | Mycophenolate mofetil, for suspension | 100 mg | oral |
| J7514 | Mycophenolate mofetil, oral suspension | 100 mg | |
| J7517 | Mycophenolate mofetil | 250 mg | oral |
| J7518 | Mycophenolic acid | 180 mg | oral |
| J8650 | Nabilone | 1 mg | oral |
| J3530 | Nasal vaccine inhalation | ||
| J8655 | Netupitant 300 mg and palonosetron 0.5 mg | oral | |
| J7699 | Noc drugs, inhalation solution administered through dme | ||
| J7799 | Noc drugs, other than inhalation drugs, administered through dme | ||
| J9999 | Not otherwise classified, antineoplastic drugs | ||
| J0752 | lenacapavir, fda approved prescription, only for use as hiv pre-exposure prophylaxis | 300 mg | Oral |
| J7676 | Pentamidine isethionate, compounded product, administered through dme, unit dose form | per 300 mg | inhalation solution |
| J2545 | Pentamidine isethionate, fda-approved final product, non-compounded, administered through dme, unit dose form | per 300 mg | inhalation solution |
| J1097 | Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution | 1 ml | |
| J7510 | Prednisolone oral | per 5 mg | |
| J7512 | Prednisone, immediate release or delayed release | 1 mg | oral |
| J7506 | Prednisone | per 5 mg | oral |
| J8999 | Prescription drug, chemotherapeutic, nos | oral | |
| J8499 | Prescription drug, non chemotherapeutic, nos | oral | |
| J7168 | Prothrombin complex concentrate, kcentra, per i.u. of factor ix activity | ||
| J3403 | Revakinagene taroretcel-lwey, per implant | ||
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme | 1 microgram | |
| J2787 | Riboflavin 5'-phosphate, ophthalmic solution | up to 3 ml | |
| J7120 | Ringers lactate infusion | up to 1000 cc | |
| J8670 | Rolapitant | 1 mg | oral |
| J7294 | Segesterone acetate and ethinyl estradiol 0.15mg, each | 0.013mg per 24 hours; yearly vaginal system | |
| J0601 | Sevelamer carbonate | 20 mg | oral |
| J0602 | Sevelamer carbonate, powder | 20 mg | oral |
| J0603 | Sevelamer hydrochloride | 20 mg | oral |
| J7520 | Sirolimus | 1 mg | oral |
| J0605 | Sucroferric oxyhydroxide | 5 mg | oral |
| J7508 | Tacrolimus, extended release | 0.1 mg | oral |
| J7503 | Tacrolimus, extended release | 0.25 mg | oral |
| J7521 | Tacrolimus, granules, oral suspension | 0.1 mg | |
| J7507 | Tacrolimus, immediate release | 1 mg | oral |
| J7525 | Tacrolimus, parenteral | 5 mg | |
| J8700 | Temozolomide | 5 mg | oral |
| J7680 | Terbutaline sulfate, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7681 | Terbutaline sulfate, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J1073 | Testosterone pellet, implant | 75 mg | |
| J7685 | Tobramycin, compounded product, administered through dme, unit dose form | per 300 milligrams | inhalation solution |
| J7682 | Tobramycin, fda-approved final product, non-compounded, unit dose form, administered through dme | per 300 milligrams | inhalation solution |
| J3389 | Topical administration, prademagene zamikeracel, per treatment | ||
| J8705 | Topotecan | 0.25 mg | oral |
| J7686 | Treprostinil, fda-approved final product, non-compounded, administered through dme, unit dose form | 1.74 mg | inhalation solution |
| J7683 | Triamcinolone, compounded product, administered through dme, concentrated form, per milligram | inhalation solution | |
| J7684 | Triamcinolone, compounded product, administered through dme, unit dose form, per milligram | inhalation solution | |
| J3590 | Unclassified biologics | ||
| J3591 | Unclassified drug or biological used for esrd on dialysis | ||
| J3490 | Unclassified drugs | ||
| J3358 | Ustekinumab, for intravenous injection | 1 mg | |
| J3357 | Ustekinumab, for subcutaneous injection | 1 mg | |
| J0901 | Vadadustat | 1 mg | oral |
| J9370 | Vincristine sulfate | 1 mg |